FDA Approves Epidiolex to Treat Seizures From Tuberous Sclerosis
The cannabis-derived oral spray can now be prescribed for seizures associated with tuberous sclerosis complex (TCS), a rare genetic condition that causes benign tumors to develop in different parts of the body.
Nevada Authorities Investigate Three Dispensaries For Selling Contaminated Flower
The Nevada Cannabis Compliance Board has begun investigating three state dispensaries for selling a product that twice failed microbial testing.
Federal Scientists Launch Hemp Program to Help Standardize Testing Methods
The scientists behind the new initiative at the National Institute of Standards and Technology also plan to help standardize the testing methods used for cannabis products, such as edibles, tinctures, and balms.
FDA Submits New CBD Policies to White House for Review
If given approval, the new regulations could come into effect in a matter of weeks.
Hemp Pet Products Recalled Due to High Lead Levels, FDA Announces
A US company is voluntarily recalling a swathe of hemp tincture products, intended for dog, cat, and human consumption, after the Florida Department of Health tested some samples and found dangerous levels of lead.
Nebraska Approves its First Hemp Testing Lab
Cannabis Testing Laboratories, which received ISO-certification in early July, was later added to Nebraska’s Department of Agriculture’s list of approved hemp testing facilities.
Rhode Island Licenses its First Medical Cannabis Lab
Up until Green Peaks’ approval, any medical cannabis sold in Rhode Island dispensaries had either been tested by growers, by the dispensaries, or by unlicensed, private labs.
European Commission Considers Reclassifying CBD as a Narcotic
The review has paused over 50 applications from CBD companies hoping to acquire a “novel food” status for their products.
CBD in the UK: Predictions for 2021
For all the excitement, the UK’s CBD industry is actually facing a roadblock, writes Professor Mike Barnes.
